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Abstract
Introduction: There is a need to investigate the effectiveness and appropriateness of antibiotics prescription within the
Integrated Management of Childhood Illness (IMCI) strategy in the context of routine outpatient clinics.
Methods: Making use of a passive case detection system established for a malaria prevention trial in outpatient clinics in
Papua New Guinea, the appropriateness and effectiveness of the use of antibiotics within the IMCI was assessed in 1605
young children. Main outcomes were prescription of antibiotics and re-attendances within 14 days for mild pneumonia,
mild diarrhoea and uncomplicated malaria whether they were managed with or without antibiotics (proxy of effectiveness).
Appropriateness was assessed for both mild and severe cases, while effectiveness was assessed only for mild diseases.
Results: A total of 6975 illness episodes out of 8944 fulfilled inclusion criteria (no previous attendance ,14 days+full
medical records). Clinical incidence rates (episodes/child/year; 95% CI) were 0.85 (0.81–0.90) for pneumonia, 0.62 (0.58–0.66)
for malaria and 0.72 (0.65–0.93) for diarrhoea. Fifty three percent of 6975 sick children were treated with antibiotics, 11%
were not treated with antibiotics when they should have been and in 29% antibiotics were prescribed when they should
not have been. Re-attendance rates within 14 days following clinical diagnosis of mild pneumonia were 9% (126/1401)
when managed with antibiotics compared to 8% (56/701) when managed without (adjusted Hazard Ratio (aHR) = 1.00
(0.57–1.76), p = 0.98). Rates for mild diarrhoea were 8% (73/874) and 9% (79/866) respectively (aHR= 0.8 (0.42–1.57),
p = 0.53).
Conclusion: Non-adherence to IMCI recommendations for prescription of antibiotics is common in routine settings in Papua
New Guinea. Although recommended, the use of antibiotics in young children with mild pneumonia as defined by IMCI
criteria did not impact on their outcome. Better tools and new strategies for the identification of bacterial infections that
require antibiotics are urgently needed.
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Introduction
Worldwide, the leading causes of death in children under five
years (excluding perinatal mortality) are pneumonia, diarrhoea
and malaria. These three diseases are responsible for an estimated
5 million deaths yearly, over 90% of which occur in Africa and
other developing countries with limited resources. [1] [2] At a
community level and in outpatient settings, the few available
studies show that pneumonia, diarrhoea and malaria are similarly
responsible for a high burden of morbidity in developing countries
[3,4,5,6,7].
For decades, a high importance was given to malaria as a cause
of fever, which has led to an overestimation of its burden and at
the same time an underestimation of other diseases. [8,9]
Nowadays, case management strategy of sick children under five
years in developing countries is usually based on clinical
presentation of diseases (syndromes) rather than on aetiologies,
as recommended by the World Health Organization (WHO),
which developed the Integrated Management of Childhood Illness
(IMCI) guidelines for this purpose. [10] The syndromic approach
has some limitations such as the potential overlap of signs and
symptoms between different diseases. [11,12,13] It remains
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unclear whether this overlap of signs/symptoms is because
children are commonly infected with multiple pathogens, or
because distinct diseases present with the same clinical picture
[11,12].
Although the IMCI strategy has been used for more than 20
years, few studies have investigated its effectiveness and appropri-
ateness. Specifically, there is limited information on how well
health workers comply with IMCI guidelines in routine practice,
and on the impact of IMCI recommendations on health outcomes.
[14,15] Although most experts agree that the introduction of
IMCI has improved the quality of care at limited cost, [16] IMCI
has however some limitations such as the absence of objective
diagnostic tools or no consideration of the local epidemiology. All
may result in low specificity of IMCI algorithms, especially to
identify bacterial infections that require antibiotics.
[3,15,16,17,18,19,20] Therefore, many children might receive
unnecessary antibiotics. Furthermore, it still remains debated how
many children who receive antibiotics prescribed according to
IMCI recommendations benefit from them. For example, a study
from Pakistan demonstrated that children with mild pneumonia
did not benefit from antibiotics. [21] This study was conducted in
controlled conditions with defined inclusion and exclusion criteria.
No study investigated the accuracy of diagnosis and the impact of
appropriate treatment on health outcomes in routine practice.
Papua New Guinea (PNG) has a high burden of malaria in
coastal areas, while pneumonia is the leading cause of admission in
children under five years nationally. [22,23,24] Case management
of sick children is almost exclusively syndrome-based using IMCI
guidelines. In outpatient settings, few diagnostic tools are available
and until 2011 microscopy or RDTs were rarely available in
health facilities to confirm malaria infections. Thus, presumptive
treatments with antimalarials and/or antibiotics are prescribed to
cover common diseases such as pneumonia, malaria or otitis
media. In PNG, as in many places, no data are available on the
performance of the IMCI strategy in outpatient settings.
As part of a trial on malaria prevention, a passive case detection
system was set up to record illness episodes in all study participants
aged 3 to 27 months. All illness episodes were managed in
accordance with the PNG IMCI guidelines, except for malaria,
where treatment was guided by RDT instead of using presumptive
diagnosis. [25] This study provides therefore a unique opportunity
to investigate the appropriateness and effectiveness of antibiotics
prescribed within IMCI.
Methods
This work was carried out alongside a 3-arm trial of
Intermittent Preventive Treatment for malaria in infants (IPTi)
that included 1605 children 3–27 months old from June 2006 to
June 2010 (www.ClinicalTrials.gov: NCT00285662) [26].
Study Sites and Population
The study took place in two regions of PNG: Mugil (Madang
Province) with 1125 study participants and in the Wosera (East
Sepik Province) with 480 study participants. Each study site
included approximately 20 villages, serviced by four major health
centres: Mugil and Alexishafen in Madang area, and Kunjingini
and Kaugia in Wosera. Several aid posts were also used for the
morbidity surveillance. All IPTi preventive treatments were given
at time of routine vaccination at 3, 6 and 9 months or of Vitamin
A supplementation at 12 months following the PNG national
expanded programme of immunization.
The study was carried out in accordance with Good Clinical
Practice (GCP) and monitored by an independent external
monitor. The study was approved by the PNG Medical Research
Advisory Committee (MRAC number 05.20). Parents or carers
were asked to fill a written consent form prior to enrolment of their
child in the trial.
Children enrolled in the trial were randomly allocated to receive
placebo or two different antimalarial drug regimes [sulphadoxine/
pyrimethamine (single dose) with either 3 days of amodiaquine
(SP-AQ3) or 3 days of artesunate (SP-AS3)]. The primary
objective of the trial was the determination of the protective effect
of the two IPTi regimens on malaria episodes.
Morbidity Surveillance
Throughout the trial, a passive case detection system was
maintained at the four study health centres’ outpatient clinics as
well as at four aid posts to assure a continuous morbidity
surveillance of study participants. This means that parents of study
participants were asked to attend the study clinics free of charge
for clinical management whenever their child was sick. They were
seen by study nurses, often in collaboration with the health centre’s
staff. No active follow-up of study participants was performed for
acute diseases (such as regular home visits). In that perspective, this
approach is more likely to reflect routine practice in PNG and thus
avoid overestimation of the burden of diseases. The passive
surveillance records collected were used to perform the present
analysis.
Each illness episode was assessed by study staff using a standard
case report form. Main signs and symptoms were systematically
recorded using tick boxes. In case of history of fever in the past 48
hours or an axillary temperature .37.5uC, a RDT for malaria
(ICT ComboH, South Africa) was performed and haemoglobin
(Hb) level measured using a portable Hemocue 201H machine
(Angelholm, Sweden). Malaria treatment decision was based on
the RDT result, and only children with a positive result were
treated with artemether/lumefantrine, irrespective of the species.
The children with moderate to severe anaemia (Hb,8 g/dl)
received iron supplementation at the dose of 5 mg/Kg of ferrous
sulphate for 6 weeks. Pulse oximetry was implemented in
December 2007 in Mugil study clinic (Madang site) and used
systematically to assess sick study participants from that date
onwards. It was recommended to clinical staff that they should
consider admitting the child if oxygen saturation dropped below
94%. All other illnesses were treated according to the standard
treatment guidelines of PNG, which is based on IMCI. [27]
Children were also assessed for danger signs or symptoms and
referred to the health centre for admission when necessary. If
children attended the health centre when study staff were not on
duty, they received care from the regular health centre nursing
staff. As they did not have the capacity to perform RDTs or other
blood tests, treatment was delivered on presumptive diagnosis
only. On site, study nurses recorded their presumptive diagnosis
and provided treatment. All records were cross-checked by the
study clinicians who confirmed the likely diagnosis. Both study
nurses and clinicians could record as many as 3 different diagnoses
for each episode.
A severe disease was defined as an illness episode with potential
life-threatening features such as respiratory distress (nasal flaring
or chest indrawing), impaired consciousness or severe pallor. At
least one danger sign or symptom needed to be present for an
episode to be classified as severe disease. A child with criteria for
severe disease was not necessarily admitted for the following
reasons: parents refused admission; health staff decided not to
admit the child according to their personal judgment or because
they did not identified properly danger signs and symptoms.
IMCI and Antibiotics Effectiveness in PNG
PLOS ONE | www.plosone.org 2 March 2014 | Volume 9 | Issue 3 | e90990
Study Staff
The medical staff was composed of about 20 nurses and
community health workers (CHW). They were specifically trained
for malaria and anaemia management in line with the trial’s
requirements (diagnosis and treatment). [26] For all other diseases
(e.g. pneumonia, diarrhoea or otitis media), they were asked to
follow the national recommendations. No specific training was
provided for IMCI, except a broad refresher training of one day
per year on the basic management of sick children, including
measurement of respiratory rate, evaluation of danger signs and
key features of IMCI. Therefore, the care provided for non-
malarial illness episodes was very close to what is usually
performed in government health facilities, except that there was
no shortage of drugs and consumables.
Laboratory Procedures
A finger prick blood sample was used to perform a rapid
diagnostic test (RDT) for malaria on site (to guide malaria
treatment) and to record haemoglobin concentration. A blood
slide was prepared for expert microscopy that was performed
elsewhere.
Coding of Diagnosis and Treatments
Using records of signs and symptoms (tick boxes) of the passive
case detection forms, objective diagnoses were generated by
computer according to IMCI definitions of diseases (e.g. mild
pneumonia = cough and/or difficulties in breathing+respiratory
rate .50 if ,1 year or respiratory rate .40 if .1 year without
sign/symptom of severity). For the present study, three diseases
were explored with different levels of severity according to IMCI:
1) mild and moderate-to-severe pneumonia, 2) mild and severe
diarrhoea and 3) uncomplicated and severe malaria. Table 1
displays the detailed definitions of the different syndromes based
on IMCI criteria. We use the terminology of the PNG-specific
IMCI guidelines that was in use at the time of the study. Table 1
includes the correspondence with the WHO-IMCI classification.
Ten distinct treatment categories were created: 1) artemether/
lumefantrine, 2) iron+folic acid, 3) albendazole, 4) amoxicillin, 5)
co-trimoxazole, 6) paracetamol, 7) tinidazole, 8) other antibiotics
(erythromycin, benzylpenicillin im, chloramphenicol and ceftria-
xone iv/im), 9) other antimalarial drugs (artemether, quinine,
amodiaquine, sulphadoxine/pyrimethamine, chloroquine, 10)
other drugs.
Study Procedure
Illness episodes were included in the study if they fulfilled the
following inclusion criteria:
N IPTi study participant
N No illness episode in the past 14 days (to avoid counting the
same episode twice)
N Full clinical records (signs and symptoms available)
The appropriateness of the prescription of antibiotics by health
staff was assessed for main diagnoses according to the IMCI
recommendations, including both severe and mild disease
episodes.
The effectiveness of antibiotics was investigated for mild diseases
only, by calculating the rate of re-attendance within 14 days and
the outcome upon re-attendance (death, severe illness or mild
disease) for specific syndromes depending whether they were
treated with antibiotics or not. Severe cases were excluded from
this analysis for several reasons: i) severe cases (i.e. with danger
signs) had to be admitted according to recommendations and
managed systematically with intravenous antimalarial and antibi-
otics irrespective of the symptoms and signs; ii) the low prevalence
of severe cases, which are almost all treated with antibiotics,
prevent the investigation of the effectiveness because of the
absence of a valid control group; iii) re-attendance rates was used
as a proxy for effectiveness, but this is not a valid measure for
assessing effectiveness in severe cases, as they should be all
admitted in the first place and would therefore not re-attend; iv)
there is no debate yet on the benefit of treating all severe cases with
antibiotics.
This analysis was possible as syndromes were not necessarily
correctly identified by health staff and therefore some children did
not receive antibiotics when they should have.
Statistical Analysis
All data were double entered using FoxPro software. Data
analyses were performed using STATA software (version 12.0).
More than one diagnosis was possible for each illness episode.
Incidence rates were calculated using a negative binomial
regression model. Cox regression model was used to calculate
hazard ratios for the impact of antibiotics on pneumonia,
diarrhoea and malaria (excluding severe diseases). The model
was adjusted for potential confounders (markers of severity of
respiratory infections): respiratory rate (continuous), temperature
(continuous) and pulse oximetry (continuous). Kaplan-Meier
survival curves were also calculated and displayed as time to first
re-attendance over a 14-day observation period following an initial
pneumonia, malaria or diarrhoea. All rates are displayed with a
confidence interval of 95%. Differences between rates were
assessed using a chi square test.
Results
Baseline Characteristics
Out of 1605 children 1512 (94%) presented at least 1 illness
episode (Madang = 1053 and Maprik = 459). The morbidity
surveillance recorded a total of 8943 illness episodes (Ma-
dang = 5977 and Maprik = 2966). Three hundred seventy one
severe illnesses and 13 deaths occurred during the study. Overall,
2903 illness episodes occurred in the placebo group, compared to
3038 in the SP-AQ group and 3002 in the SP-AS arm.
Inclusion criteria were fulfilled for 6975 illness episodes (no visit
in the previous 14 days and full medical records available).
Table 2 displays the danger signs and symptoms, clinical and
laboratory features. As shown, 80% of the illness episodes
presented with fever/history of fever and 76% had cough. No
significant difference was observed between the different IPTi
treatment groups (data not shown).
Description of Main Diseases According to IMCI Criteria
and their Incidence Rates
Out of the 6975 illness episodes, 76.5% (5335) were ARI,
including 44.7% (3116) URTI, 30.1% (2102) mild pneumonia and
1.7% (117) severe pneumonia. 25.6% (1788) had diarrhoea,
including 24.9% (1740) mild diarrhoea and 0.7% (48) severe
diarrhoea. 25.1% (1750) had malaria, including 23.6% (1643)
uncomplicated malaria and 1.5% (107) severe malaria. 10.2%
(710) could not be classified in one of these syndromes. In this
category, there were mainly children with running nose as single
symptom (which cannot be classified as URTI according to IMCI),
skin infections and fever without any other accompanying
symptom.
The incidence rates (IR, episode/child/year) were 0.85 (95%
CI, 0.81–0.90) for mild pneumonia, 0.72 (95% CI, 0.65–0.93) for
IMCI and Antibiotics Effectiveness in PNG
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mild diarrhoea and 0.62 (95% CI, 0.58–0.66) for uncomplicated
malaria. No differences were found in the incidence of non-
malarial illnesses between the placebo and IPTi intervention arms.
Indeed, incidence rates for all pneumonia in children 3–15 months
old were very similar in all arms with 0.97 (95% CI, 0.89–1.06) in
the placebo group, 1.00 (95% CI, 0.92–1.09) in the SP-AQ3 group
and 0.98 (95% CI, 0.90–1.07) in the SP-AR3 group, p-values for
incidence rate ratios (IRR) were 0.63 and 0.87 respectively. For
diarrhoea (severe included), the incidence rates from 3–15 months
were similar in all arms with: 0.94 (95% CI, 0.86–1.02) for
placebo, 0.92 (95% CI, 0.84–1.0) for SP-AQ3 and 0.89 (95% CI,
0.81–0.99) for SP-AS3, p-values for IRR were 0.85 and 0.51
respectively. By contrast, the IPTi has proven to be effective on
malaria as described elsewhere. Main results showed that the
incidence of clinical malaria between the first dose at 3 months
and 15 months was 0.85 per year-at-risk overall and 0.22 and 0.68
for P. falciparum and P. vivax, respectively. In the intention-to-
treat analyses, the protective efficacy against all cases of malaria
was 29% ([95% CI, 0.10, 0.43], p =,0.001) in the SP-AQ3 group
and 12% ([95% CI, 20.11, 0.30], p = 0.12) in the SP-AS3 group
[26].
Use of Antibiotics and Appropriateness of Prescription
Out of the 6975 illness episodes, 53.6% (3741) were treated with
antibiotics (at least one of amoxicillin, co-trimoxazole, erythromy-
cin or i.m. penicillin or ceftriaxone) and 25.1% (1750) received
antimalarial drugs (97.6% of whom had a positive RDT result).
Among the children who were treated for mild pneumonia with
antibiotics, 69% received amoxicillin only, 9% received co-
trimoxazole only, 16% received other antibiotics and 6% received
a combination of amoxicillin and other antibiotics.
The overall appropriateness of antibiotics use was evaluated in
6969 illness episodes for which clear recommendations exist in the
IMCI whether to prescribe or not antibiotics. According to these
data, 40% of children were not treated appropriately, of whom
11% did not receive antibiotics when they should have and 29%
received antibiotics when they should not have. (Figure 1).
Among the 2102 children with an objective diagnosis of mild
pneumonia, 66.7% (1401) received (appropriately) antibiotics. Of
532 children who presented with criteria for both mild pneumonia
and uncomplicated malaria (based on positive RDT), only 40%
(213) were prescribed antibiotics. In contrast, when they had
criteria for pneumonia only (without malaria), 75.7% (1188/1569)
were prescribed antibiotics (p,0.001). Among 117 children with a
diagnosis of severe pneumonia, 96.6% (113) received antibiotics, of
whom 75.2% (88) were treated with parenteral antibiotics as per
WHO guidelines and 49.6% (58) were admitted.
Effectiveness of Antibiotics for Mild Pneumonia,
Uncomplicated Malaria and Mild Diarrhoea
Re-attendance rate within 14 days following an objective
diagnosis of mild pneumonia (IMCI criteria) was 9% when treated
with antibiotics compared to 8% when they did not receive any
antibiotics, unadjusted Hazard Ratio (HR) was 1.09 (95% CI
0.80–1.49, p = 0.59). For uncomplicated malaria, re-attendance
rates were 4% when they received antibiotics vs 6% when they
did not [HR 0.66 (95% CI 0.39–1.10, p = 0.11)]. For diarrhoea,
Table 1. Definition of diseases (including the use of RDT for malaria).
Criteria Standard treatment WHO IMCI terminology
Respiratory infections
Acute Respiratory Infection (ARI) Cough and/or difficulties in breathing ARI
Upper Respiratory Tract
Infection (URTI)
Cough and/or difficulties in breathing AND RR,50
(,1 Y) RR,40 (.1 y) AND No respiratory
distress (chest indrawing, cyanosis, nasal flaring)
Paracetamol no pneumonia/cough and
cold
All pneumonia Cough and/or difficulties in breathing AND RR.50
(,1 Y) RR.40 (.1 y)
n/a
mild pneumonia Cough and/or difficulties in breathing AND RR.50
(,1 Y) RR.40 (.1 y) AND No respiratory
distress (chest indrawing, cyanosis, nasal flaring)
Amoxicillin 5 days non-severe pneumonia
Severe pneumonia Cough and/or difficulties in breathing AND RR.50
(,1 Y) RR.40 (.1 y) AND Respiratory distress
(chest indrawing, cyanosis, nasal flaring)
Benzylpenicillin im or
chloramphenicol
im 10 days, admit
severe and very severe
pneumonia
Diarrhoea
All diarrhoea Diarrhoea and/or vomit n/a
Mild diarrhoea Diarrhoea and/or vomit AND No dehydration
(slow skin pinch, sunken eyes)
more hydration+breast
feed
No or some dehydration
Severe diarrhoea Diarrhoea and/or vomit AND dehydration
(slow skin pinch, sunken eyes)




All malaria Fever and/or history of fever in past 48 h
AND positive RDT (any species)
n/a
Uncomplicated malaria Fever and/or history of fever in past 48 h






Severe malaria Fever and/or history of fever in past 48 h
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re-attendance rates were 8% when they received antibiotics and
9% when they did not [HR 0.85 (95% CI 0.61–1.16, p = 0.3)].
When adjusting for potential confounders including severity
parameters (respiratory rate, pulse oximetry and fever), the
adjusted HR (aHR) for mild pneumonia was 1.00 (95% CI,
0.57–1.76, p = 0.98), for mild malaria 0.70 (0.31–1.59, p = 0.39)
and for mild diarrhoea 0.81(0.42–1.566, p = 0.53). Figure 2
displays the re-attendance rates and outcomes within 14 days
following the initial consultation for mild pneumonia, uncompli-
cated malaria and mild diarrhoea according to the prescription of
antibiotics. Figures 3a, 3b, 3c displays the Kaplan-Meyer
survival curves for these three diseases whether they were
managed with or without antibiotics. There was no significant
difference between the curves with or without antibiotics for all
three diseases.
Discussion
The aim of this prospective study was to explore the
appropriateness and effectiveness of prescription of antibiotics in
routine outpatient settings of Papua New Guinea in the frame of
the IMCI recommendations.
Overtreatment with Antibiotics
A high rate of antibiotic prescription was observed in the cohort,
with 54% of cases treated (including mild and severe cases) when a
maximum of 36% should have received antibiotics according to
IMCI criteria, This is high compared to other settings, where it is
usually reported that approximately 20% of patients require
antibiotics when the diagnosis is made by highly skilled clinicians.
[7,15] This high rate of prescription may be due to difficulties in
accurately recognizing or measuring signs and symptoms by health
staff. For example, it is frequently observed that respiratory rate is
not properly assessed and therefore tachypnoea often overesti-
mated. In our setting, despite the official recommendation of
counting over 1 minute, most respiratory rates were even numbers
suggesting that health workers are not counting according to
standard operating procedures. (Senn & Rarau, personal commu-
nication) This is especially worrying as tachypnoea is a cornerstone
for the diagnosis of pneumonia and hence for the prescription of
Table 2. Clinical and paraclinical features of 6975 illness episodes.
% (N)
Danger signs
Unable to eat 0.6 44
Vomit everything 0.5 38
Unconscious/drowsy 1.4 95
Respiratory distress 1.7 117
Fits 0.8 58
Inability to sit up 0.2 12
Neck stifness 0.1 8
Severe Dehydration 0.7 49
Pale with heart rate .160 or oedema 0.2 17
Main signs, symptoms
Fever (temp.37.5u/hist of fev) 80.3 5603
Palor 2.7 185
Cough 76.4 5332
Difficulties in breathing 14.9 1037
Running nose 46.2 3207
Diarrhoea 21.1 1474
Abdominal pain 2.7 191
Vomit 10.2 713
Ear pain 0.6 44
Skin rash 0.3 13
Skin abscess 1 67
Pus out of the ear 2.6 183
Respiratory rate .50 19.9 1390
Laboratory findings
Pulse O2,94% 3.4 54*
Pulse O2,93% 2.7 42*
Mean Hb level (g/L) 9.6 –
Hb ,8 g/L 11.1 626**
*only 1582 records with pulse oxymetry measured.
**only 5644 records with Hb measured.
doi:10.1371/journal.pone.0090990.t002
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Figure 1. Appropriateness of antibiotics’ use according to the IMCI recommendations.
doi:10.1371/journal.pone.0090990.g001
Figure 2. Re-attendance rates within 14 days and outcomes for the most common mild syndromes according to the prescription of
antibiotics.
doi:10.1371/journal.pone.0090990.g002
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antibiotics. Improving skills and eventually finding new tools for
the accurate determination of the respiratory rate would be an
important step towards more rational use of antibiotics.
Appropriateness of Antibiotics Prescription
A poor compliance to guidelines was observed as 40% of
patients were not treated according to the recommendations (29%
received antibiotics when they should not have and 11% did not
receive antibiotics when they should have). Apart from the
inaccurate clinical judgment of health staff, other factors might
influence their decision. In our study, we observed that the
prescription of antibiotics was strongly influenced by the result of
the RDT for malaria in feverish patients. Indeed, we observed that
in children presenting with criteria for mild pneumonia (who
should receive antibiotics), only 40% were treated when the RDT
was positive, compared to 76% when the test was negative. On
one hand, it is reassuring to observe that clinicians are influenced
in their clinical judgment and treatment attitude by an objective
test. On the other hand, considering only one diagnosis may have
potential serious consequences for children, as it might leave
children with bacterial infections untreated. This may be the
downside of the introduction of RDT in routine clinics. Indeed,
improving the diagnosis of malaria may have adverse effects for
the management of other diseases, which is in line with findings by
Bisoffi et al. in Africa [28]. This will need to be addressed when
redesigning guidelines.
It is finally reassuring to observe that almost all children (97%)
with criteria for a severe pneumonia received antibiotics.
Effectiveness of Antibiotics
One might worry that such a high rate of non-compliance to
standard IMCI recommendations might leave a lot of children
with potential bacterial pneumonia untreated and might re-attend
with a more severe clinical presentation associated with poor
outcomes. However, our data indicate that it is in fact not the case.
Indeed, the rate of re-attendance following a visit for mild
pneumonia, which can be considered as a proxy of the
effectiveness of the antibiotics, was similar, irrespective of
antibiotic prescription (9% when they received antibiotics and
8% if they did not, adjusted hazard ratio of 1.0). This is well in line
with recent findings in Pakistan where the use of amoxicillin was
not found to provide any benefit for non-severe pneumonia as
defined by WHO. [21] More generally and from a policy
perspective, IMCI guidelines are not only aiming at reducing
under five mortality by providing efficient strategies to treat acute
severe cases but also to prevent the worsening of mild diseases. In
that perspective, it was postulated that the broad prescription of
antibiotics should mitigate the risk of poor outcomes. Our study
looked specifically at that aspect in an outpatient setting and
provides solid evidence to demonstrate that treating broadly mild
diseases with antibiotics does not help prevent severe diseases.
Recently, WHO and UNICEF, aware of the lack of specificity of
Figure 3. Kaplan–Meier estimates of the proportion of patients with mild pneumonia (3a), mild malaria (3b) or gastroenteritis (3c)
re-attending the clinics within 14 days whether they received antibiotics (red line) or not (blue line).
doi:10.1371/journal.pone.0090990.g003
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the current IMCI guidelines, revised their recommendations and
proposed a new classification of respiratory infections, notably
merging non-severe and severe pneumonia into ‘‘pneumonia’’ and
‘‘severe pneumonia’’ being reserved for children with danger signs.
The results of the present study validate and support this revision.
The absence of difference in the re-attendance rates is probably
due to the fact that the vast majority of mild pneumonia episodes
have a viral aetiology rather than bacterial, highlighting the lack of
specificity of the clinical criteria to identify bacterial pneumonia.
This was confirmed by a microbiological investigation made on
nasal swabs in a sub-sample of these children. The rapid antigen
diagnostic tests for viral pathogens showed that more than half of
children with mild clinical pneumonia were positive for at least
one of the four most common respiratory viruses: Influenza A&B,
Adenovirus and Respiratory Syncytial Virus (Rarau et al. personal
communication). Similar findings have also been published in
other countries. [7] The fact that mortality was very low and most
pneumonias were treated with amoxicillin (instead of co-trimox-
azole), speaks against the hypothesis that similar outcomes
between antibiotics users and non-users were due to the high
prevalence of resistant pathogens [29].
The diagnosis of pneumonia is more complex than that of
malaria as no reliable and easy-to-use tests are available to identify
respiratory infections that require antibiotics. It has been
recognized that pneumonia is often associated with virus detection
and that there is a complex and poorly understood interplay
between viruses and bacteria in the development of pneumonia.
[30] Considering the dramatically high burden of respiratory
illnesses, especially in very young children, the development of
more accurate diagnostic strategies able to identify children with
pneumonia requiring antibiotics should be on the top list of
priorities. [7] The potential benefits of the use of RDT to
document viral pathogens such as RSV or Influenza need to be
investigated. Beyond the aetiology of respiratory infections, it
would be also valuable to develop tests able to identify children
with potentially severe (invasive) diseases, which require specific
supportive care. In that regard, inflammatory markers such as pro-
calcitonin (PCT) can be valuable tools. Recent reviews by Schuetz
et al. [31,32] have shown that PCT-guided prescription of
antibiotics for ARI was safe and reduce substantially the
consumption of antibiotics. They also noted that evidence is
lacking on usefulness of PCT in settings outside Europe. C -
reactive protein (CRP) can be also another valuable biomarker but
results of randomized trials and meta-analysis are more conflicting.
[33,34,35,36] Finally, more experimental tools such as analysis of
exhaled gases could be also considered [37]. New recommenda-
tions that integrate clinical assessment and biomarkers for the
identification of cases that require antibiotics need to be seriously
considered. However, further pragmatic research is needed to
explore the most efficient, safe and cost-effective approach in
children in resource-limited countries.
Similarly to what was observed with mild pneumonia,
antibiotics did not provide any benefit for diarrhoea or malaria
in our cohort, which supports the current WHO recommendations
of not treating mild gastroenteritis and uncomplicated malaria
with antibiotics.
Limitations of the Study
The main limitation of this study is that the clinical
management of malaria episodes was performed in ideal
conditions because it was conducted alongside a malaria
prevention trial (i.e. treatment of only RDT positive cases). While
RDT-based malaria treatment was not part of the PNG malaria
treatment guidelines when the study was conducted, there was
rapid roll-out and rapid up-take of RDTs [38] and the situation in
our study therefore increasingly resembles the situation in almost
all malaria endemic countries including PNG. On the other hand,
for all other diseases, the recommendations made to the study
nurses were identical to the national standard treatment protocols.
Another limitation is the lack of randomization for the use of
antibiotics, which might have led to selection biases. However,
even when we adjusted for potential confounders of disease
severity (such as respiratory rate or pulse oximetry), no significant
difference was observed whether illness episodes were treated with
antibiotics or not.
Conclusions
This study shows that adherence to IMCI recommendations for
prescription of antibiotics was poor in routine outpatient settings of
Papua New Guinea and was strongly influenced by RDT results
for malaria, independently of the clinical presentation. However,
the management of mild pneumonia with antibiotics based on
IMCI guidelines did not change health outcome in terms of re-
attendance and complications when compared to no antibiotics.
This absence of effectiveness of antibiotics is certainly due to the
lack of specificity of the present recommendations to differentiate
children with true bacterial diseases and those with viral infections.
It is urgently needed to develop better strategies to improve the
identification of pneumonia and other syndromes that require
antibiotics or more intensive clinical care.
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